Role of NFκB in an Animal Model of Complex Regional Pain Syndrome-type I (CRPS-I)

Journal of Pain

Volumn 10, Issue 11, 2009, Pages 1161-1169

  de Mos, Marissa ^a   Laferrière, André ^b   Millecamps, Magali ^b,c   Pilkington, Mercedes ^b   Sturkenboom, Miriam C J M ^a   Huygen, Frank J P M ^a   Coderre, Terence J ^b,c,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Chronic postischemia pain; CPIP; inflammation; ischemia; neuropathic pain; PDTC; pyrrolidine dithiocarbamate; reperfusion

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLIDINE DITHIOCARBAMATE; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; THIOCARBAMIC ACID DERIVATIVE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC POSTISCHEMIA PAIN; COMPLEX REGIONAL PAIN SYNDROME TYPE I; MALE; MEASUREMENT; MUSCLE; NONHUMAN; PAIN; RAT; REPERFUSION INJURY; SPINAL CORD; ANIMAL; CELL NUCLEUS; COLD; COMPLEX REGIONAL PAIN SYNDROME; DISEASE MODEL; DOSE RESPONSE; DRUG ANTAGONISM; LONG EVANS RAT; METABOLISM; PAIN ASSESSMENT; SKELETAL MUSCLE; STIMULATION; TIME;

ANIMALS; CELL NUCLEUS; COLD TEMPERATURE; COMPLEX REGIONAL PAIN SYNDROMES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MUSCLE, SKELETAL; NF-KAPPA B; PAIN MEASUREMENT; PHYSICAL STIMULATION; PYRROLIDINES; RATS; RATS, LONG-EVANS; REPERFUSION INJURY; SPINAL CORD; THIOCARBAMATES; TIME FACTORS;

EID: 70350495611     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2009.04.012     Document Type: Article

References (55)

1. Alexander G.M., van Rijn M.A., van Hilten J.J., Perreault M.J., and Schwartzman R.J. Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain 116 3 (2005) 213-219
2. Atreya I., Atreya R., and Neurath M.F. NF-kappaB in inflammatory bowel disease. J Intern Med 263 (2008) 591-596
3. Barnes P.J., and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336 (1997) 1066-1071
4. Birklein F., Schmelz M., Schifter S., and Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology 57 (2001) 2179-2184
5. Birklein F., Weber M., Ernst M., Riedl B., Neundorfer B., and Handwerker H.O. Experimental tissue acidosis leads to increased pain in complex regional pain syndrome (CRPS). Pain 87 (2000) 227-234
6. Birrell M.A., Hardaker E., Wong S., McCluskie K., Catley M., De Alba J., Newton R., Haj-Yahia S., Pun K.T., Watts C.J., Shaw R.J., Savage T.J., and Belvisi M.G. Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. Am J Respir Crit Care Med 172 (2005) 962-971
7. Blair S.J., Chinthagada M., Hoppenstehdt D., Kijowski R., and Fareed J. Role of neuropeptides in pathogenesis of reflex sympathetic dystrophy. Acta Orthop Belg 64 (1998) 448-451
8. Blaisdell F.W. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: A review. Cardiovasc Surg 10 (2002) 620-630
9. Boone D.L., Lee E.G., Libby S., Gibson P.J., Chien M., Chan F., Madonia M., Burkett P.R., and Ma A. Recent advances in understanding NF-kappaB regulation. Inflamm Bowel Dis 8 (2002) 201-212
10. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
11. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53 (1994) 55-63
12. Chen F., Castranova V., Shi X., and Demers L.M. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 45 (1999) 7-17
13. Choi Y., Yoon Y.W., Na H.S., Kim S.H., and Chung J.M. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 59 (1994) 369-376
14. Coderre T.J., Xanthos D.N., Francis L., and Bennett G.J. Chronic post-ischemia pain (CPIP): A novel animal model of complex regional pain syndrome-type I (CRPS-I; reflex sympathetic dystrophy) produced by prolonged hindpaw ischemia and reperfusion in the rat. Pain 112 (2004) 94-105
15. Cuzzocrea S., Chatterjee P.K., Mazzon E., Dugo L., Serraino I., Britti D., Mazzullo G., Caputi A.P., and Thiemermann C. Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol 135 (2002) 496-510
16. Frangogiannis N.G. Chemokines in ischemia and reperfusion. Thromb Haemost 97 (2007) 738-747
17. Gibbs G.F., Drummond P.D., Finch P.M., and Phillips J.K. Unravelling the Pathophysiology of Complex Regional Pain Syndrome: Focus on sympathetically maintained pain. Clin Exp Pharmacol Physiol 35 (2008) 717-724
18. Gradl G., Finke B., Schattner S., Gierer P., Mittlmeier T., and Vollmar B. Continuous intra-arterial application of substance P induces signs and symptoms of experimental complex regional pain syndrome (CRPS) such as edema, inflammation and mechanical pain but no thermal pain. Neuroscience 148 (2007) 757-765
19. Guo T.Z., Wei T., and Kingery W.S. Glucocorticoid inhibition of vascular abnormalities in a tibia fracture rat model of complex regional pain syndrome type I. Pain 121 (2006) 158-167
20. Hattori Y., Hattori S., Sato N., and Kasai K. High-glucose-induced nuclear factor kappaB activation in vascular smooth muscle cells. Cardiovasc Res 46 (2000) 188-197
21. Hettne K.M., de Mos M., de Bruijn A.G., Weeber M., Boyer S., van Mulligen E.M., Cases M., Mestres J., and van der Lei J. Applied information retrieval and multidisciplinary research: New mechanistic hypotheses in Complex Regional Pain Syndrome. J Biomed Discov Collab 2 (2007) 2
22. Ho E., Chen G., and Bray T.M. Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice. Faseb J 13 (1999) 1845-1854
23. Huygen F.J., De Bruijn A.G., De Bruin M.T., Groeneweg J.G., Klein J., and Zijlstra F.J. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm 11 (2002) 47-51
24. Huygen F.J., Ramdhani N., van Toorenenbergen A., Klein J., and Zijlstra F.J. Mast cells are involved in inflammatory reactions during complex regional pain syndrome type 1. Immunol Lett 91 (2004) 147-154
25. Inoue G., Ochiai N., Ohtori S., Nakagawa K., Gemba T., Doya H., Ito T., Koshi T., Moriya H., and Takahashi K. Injection of nuclear factor-kappa B decoy into the sciatic nerve suppresses mechanical allodynia and thermal hyperalgesia in a rat inflammatory pain model. Spine 31 (2006) 2904-2908
26. Jongeneel C.V. Regulation of the TNF alpha gene. Prog Clin Biol Res 388 (1994) 367-381
27. Kalita J., Vajpayee A., and Misra U.K. Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: A randomized controlled trial. Qjm 99 (2006) 89-95
28. Kingery W.S., Davies M.F., and Clark J.D. A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II. Pain 104 (2003) 75-84
29. Koban M., Leis S., Schultze-Mosgau S., and Birklein F. Tissue hypoxia in complex regional pain syndrome. Pain 104 (2003) 149-157
30. Kurvers H., Daemen M., Slaaf D., Stassen F., van den Wildenberg F., Kitslaar P., and de Mey J. Partial peripheral neuropathy and denervation induced adrenoceptor supersensitivity. Functional studies in an experimental model. Acta Orthop Belg 64 (1998) 64-70
31. Laughlin T.M., Bethea J.R., Yezierski R.P., and Wilcox G.L. Cytokine involvement in dynorphin-induced allodynia. Pain 84 (2000) 159-167
32. Ledeboer A., Gamanos M., Lai W., Martin D., Maier S.F., Watkins L.R., and Quan N. Involvement of spinal cord nuclear factor kappaB activation in rat models of proinflammatory cytokine-mediated pain facilitation. Eur J Neurosci 22 (2005) 1977-1986
33. Lee K.M., Kang B.S., Lee H.L., Son S.J., Hwang S.H., Kim D.S., Park J.S., and Cho H.J. Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur J Neurosci 19 (2004) 3375-3381
34. Leis S., Weber M., Isselmann A., Schmelz M., and Birklein F. Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome. Exp Neurol 183 (2003) 197-204
35. Li W., Hou L., Hua Z., and Wang X. Interleukin-1beta induces beta-calcitonin gene-related peptide secretion in human type II alveolar epithelial cells. Faseb J 18 (2004) 1603-1605
36. Lieb K., Fiebich B.L., Berger M., Bauer J., and Schulze-Osthoff K. The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol 159 (1997) 4952-4958
37. Lille S.T., Lefler S.R., Mowlavi A., Suchy H., Boyle Jr. E.M., Farr A.L., Su C.Y., Frank N., and Mulligan D.C. Inhibition of the initial wave of NF-kappaB activity in rat muscle reduces ischemia/reperfusion injury. Muscle Nerve 24 (2001) 534-541
38. Matsui N., Kasajima K., Hada M., Nagata T., Senga N., Yasui Y., Fukuishi N., and Akagi M. Inhibiton of NF-kappaB activation during ischemia reduces hepatic ischemia/reperfusion injury in rats. J Toxicol Sci 30 (2005) 103-110
39. Mattson M.P., and Meffert M.K. Roles for NF-κB in nerve cell survival, plasticity and disease. Cell Death Differ 13 (2006) 852-860
40. Mestre C., Pelissier T., Fialip J., Wilcox G., and Eschalier A. A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods 32 (1994) 197-200
41. Millecamps M., and Coderre T.J. Rats with chronic post-ischemia pain exhibit an analgesic sensitivity profile similar to human patients with complex regional pain syndrome - type I. Eur J Pharmacol 583 (2008) 97-102
42. Nurmi A., Lindsberg P.J., Koistinaho M., Zhang W., Juettler E., Karjalainen-Lindsberg M.L., Weih F., Frank N., Schwaninger M., and Koistinaho J. Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 35 (2004) 987-991
43. Perez R.S., Zuurmond W.W., Bezemer P.D., Kuik D.J., van Loenen A.C., de Lange J.J., and Zuidhof A.J. The treatment of complex regional pain syndrome type I with free radical scavengers: A randomized controlled study. Pain 102 (2003) 297-307
44. Pollock G., Pennypacker K.R., Memet S., Israel A., and Saporta S. Activation of NF-kappaB in the mouse spinal cord following sciatic nerve transection. Exp Brain Res 165 (2005) 470-477
45. Richardson P.G., Sonneveld P., Schuster M.W., Irwin D., Stadtmauer E.A., Facon T., Harousseau J.L., Ben-Yehuda D., Lonial S., Goldschmidt H., Reece D., San-Miguel J.F., Blade J., Boccadoro M., Cavenagh J., Dalton W.S., Boral A.L., Esseltine D.L., Porter J.B., Schenkein D., and Anderson K.C. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 352 (2005) 2487-2498
46. Roman-Blas J.A., and Jimenez S.A. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 14 (2006) 839-848
47. Sakaue G., Shimaoka M., Fukuoka T., Hiroi T., Inoue T., Hashimoto N., Sakaguchi T., Sawa Y., Morishita R., Kiyono H., Noguchi K., and Mashimo T. NF-kappa B decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model. Neuroreport 12 (2001) 2079-2084
48. Sehgal P.B. Regulation of IL6 gene expression. Res Immunol 143 (1992) 724-734
49. Stansfield W.E., Moss N.C., Willis M.S., Tang R., and Selzman C.H. Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury. Ann Thorac Surg 84 (2007) 120-125
50. Sun T., Song W.G., Fu Z.J., Liu Z.H., Liu Y.M., and Yao S.L. Alleviation of neuropathic pain by intrathecal injection of antisense oligonucleotides to p65 subunit of NF-kappaB. Br J Anaesth 97 (2006) 553-558
51. Tegeder I., Niederberger E., Schmidt R., Kunz S., Guhring H., Ritzeler O., Michaelis M., and Geisslinger G. Specific Inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J Neurosci 24 (2004) 1637-1645
52. Uwe S. Anti-inflammatory interventions of NF-kappaB signaling: Potential applications and risks. Biochem Pharmacol 75 (2008) 1567-1579
53. van der Laan L., ter Laak H.J., Gabreels-Festen A., Gabreels F., and Goris R.J. Complex regional pain syndrome type I (RSD): Pathology of skeletal muscle and peripheral nerve. Neurology 51 (1998) 20-25
54. Watkins L.R., and Maier S.F. Beyond neurons: Evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 82 (2002) 981-1011
55. Xanthos D.N., and Coderre T.J. Sympathetic vasoconstrictor antagonism and vasodilatation relieve mechanical allodynia in rats with chronic postischemia pain. J Pain 9 (2008) 423-433